Arizona Blue Plan to Cover Gardasil
Posted on: Tuesday, 1 August 2006, 15:00 CDT
Blue Cross Blue Shield of Arizona said Tuesday it would cover Merck's recently approved cervical-cancer vaccine Gardasil.
The health insurer said coverage would be available immediately to its group and individual plan members with standard benefit plans.
The Food and Drug Administration approved the vaccine June 8 for preventing infection with the human papillomavirus -- the leading cause of cervical cancer -- in females ages nine to 26.
The FDA has stated that Gardasil is a significant advance in the protection of women's health because it strikes at the infections that are the root cause of many cervical cancers, said Gary Smethers, BCBSAZ's chief medical officer. Providing coverage for this new vaccine is a reflection of our commitment to the health of our members and is the right thing to do.
Gardasil's preventive cost is a small fraction of the total cost to treat cervical cancer, the health insurer said, with the annual cost of treating the deadly disease totaling approximately $1.7 billion annually, based on statistics from the National Cancer Institute.
Source: United Press International
Related Articles
- Medicaid Health Plans Provide Cost Savings to States and High Quality and Value to Beneficiaries, New Analysis Shows
- Department of Health Recognizes January As Cervical Health Awareness Month
- FDA Approves Expanded Indications of Merck's Gardasil Vaccine
- Bermuda Cancer and Health Centre Create Awareness Campaign With Covidien Ltd for Prostate Cancer
- Pap Tests As Important As Ever for Cervical Health
- National Cervical Cancer Coalition Stresses Importance of Screening and Prevention During January Cervical Health Awareness Month
- Merck's Gardasil Vaccine Not Proven Safe for Little Girls
- UFCW Union, Local 876: Wal-Mart's Growing Health Care Crisis Costs Taxpayers Billions
- Electronic Health Database May Cost $200 Billion
User Comments (0)

RSS Feeds